Key details
Sponsor
Massachusetts General Hospital
Collaborators
Roche Diagnostics GmbH
Enrollment target
~3,000 participants
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated December 2025